1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 22nd April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus..., 2023, Sloan at al

Discussion in 'Other health news and research' started by Maat, Apr 12, 2024.

  1. Maat

    Maat Senior Member (Voting Rights)

    Messages:
    190
    Copied post

    Also on 13 December 2023

    Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study | Rheumatology | Oxford Academic (oup.com)

    Abstract
    Objective
    Neuropsychiatric lupus (NPSLE) is challenging to diagnose. Many neuropsychiatric symptoms, such as headache and hallucinations, cannot be verified by tests or clinician assessment. We investigated prioritizations of methods for diagnosing NPSLE and attributional views.

    Methods
    Thematic and comparative analyses were used to investigate how clinicians prioritize sources of evidence from a 13-item list, and explore discordances in clinician (surveys n = 400, interviews n = 50) and patient (surveys n = 676, interviews n = 27) perspectives on attribution.

    Results
    We identified high levels of variability and uncertainty in clinicians’ assessments of neuropsychiatric symptoms in SLE patients. In attributional decisions, clinicians ranked clinicians’ assessments above diagnostic tests (many of which they reported were often unenlightening in NPSLE). Clinicians ranked patient opinion of disease activity last, and 46% of patients reported never/rarely having been asked if their SLE was flaring, despite experienced patients often having ‘attributional insight’. SLE patients estimated higher attributability of neuropsychiatric symptoms to the direct effects of SLE on the nervous system than clinicians (P < 0.001 for all symptoms excluding mania), and 24% reported that their self-assessment of disease activity was never/rarely concordant with their clinicians. Reports of misattributions were common, particularly of non-verifiable diffuse symptoms. Terminology differed between clinicians and influenced attribution estimates.

    Conclusion
    NPSLE diagnostic tests and clinician assessments have numerous limitations, particularly in detecting diffuse neuropsychiatric symptoms that can be directly attributable and benefit from immunosuppression. Our findings suggest that incorporating patient attributional insights—although also subject to limitations—may improve attribution decision-making. Consensus regarding terminology and interpretations of ‘direct attributability’ is required."

    "Patients were asked to rate measures of satisfaction with care and life as a percentage."

    Another illness with a high ratio of female patients.

    Lupus, Fatigue and Lifestyle - LUPUS UK

    " Encouraging patients to participate in regular physical activity whilst troubled by high levels of debilitating fatigue is, however, challenging."

    neuropsychiatric lupus, SLE, NPSLE, CNS lupus, patient-clinician interactions, attribution, misattribution, diagnosis, diagnostic tools, attribution
    Topic:

    • headache
    • decision making
    • diagnostic techniques and procedures
    • hallucinations
    • lupus vasculitis, central nervous system
    • nervous system
    • self assessment
    • therapeutic immunosuppression
    • natural immunosuppression
    • diagnosis
    • neuropsychiatric systemic lupus erythematosus
    • mania
    • consensus
    • verification
     
    Last edited by a moderator: Apr 14, 2024

Share This Page